Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

BACKGROUND: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. Here, tofacitinib safety and efficacy data from a long-term extension study in Japanese patients are presented. METHODS: Study A3921041 was a multi-centre, open-label, long-term extension study that...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Arthritis Res Ther
Hoofdauteurs: Yamanaka, Hisashi, Tanaka, Yoshiya, Takeuchi, Tsutomu, Sugiyama, Naonobu, Yuasa, Hirotoshi, Toyoizumi, Shigeyuki, Morishima, Yosuke, Hirose, Tomohiro, Zwillich, Samuel
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2016
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4730592/
https://ncbi.nlm.nih.gov/pubmed/26818974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0932-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items